World Alzheimer's Month
Every three seconds, someone in the world develops #dementia and Alzheimer’s disease is the leading cause. We’re committed not only to diagnosing the disease, but also to preserving what makes people who they are and giving families more time together. This World Alzheimer’s Month, we stand with patients, families, and healthcare partners, pushing the boundaries of science to chart a new course in Alzheimer’s disease. Learn more about our work in Alzheimer’s 👉 https://spkl.io/6043ATjYP #FightDementia #BrainHealth #Alzheimer
This is profoundly needed. Thank you for sharing abc I looking forward to seeing how I might assist in spreading awareness
Doing what patients need next ! A company that lives this in true sense with its actions.
Alzheimer’s isn’t just a medical challenge - it’s a human one. Every breakthrough, every early diagnosis, every moment preserved with loved ones matters. As leaders in healthcare, our responsibility goes beyond science: it’s about protecting identity, dignity, and time - the most precious resource families have. We must keep pushing, relentlessly, to change the course of this disease, Roche
Roche’s focus on simpler, earlier diagnostics is transformative — blood tests that spot changes years before symptoms could shift Alzheimer’s care from managing decline to actually changing outcomes. But it raises a question: how do we ensure healthcare systems and frontline clinics are ready to adopt these tools quickly and equitably, so families aren’t left waiting too long for answers?
Thank you for pushing the boundaries of science to fight Alzheimer's disease!
Important reminder of how science and collaboration can transform lives. Supporting patients and families in this journey is a mission that inspires us all. 👏
Beautifully said. For us, every month is World Alzheimer’s Month. At Micillic, we’re focused on complementary ways to support brain health, raising awareness, promoting prevention and lifestyle care, and advancing gut–brain science alongside clinical innovation. More time together, with dignity and support, is the goal we all share.
Alzheimer’s disease remains one of the greatest global health challenges, and advancing earlier diagnosis alongside innovative treatments is essential. It’s inspiring to see continued commitment to both science and preserving quality of life for patients and families.
The statistic is heartbreaking, but the commitment to charting a new course gives hope. Thank you for your relentless focus on patients and families. This is the kind of science the world needs.
Analytical Science & CMC Strategy Leader | Mass Spec & Biologics Development Expert
1w👏